News + Filings Transactions
|
Canan John
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/08/2022 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 8k | $0.00 | $0 | | 12/08/2022 |
| 09/28/2022 | Acasti Pharma Inc. | ACST | Grant | Stock Options (Right to Buy) | 45k | $0.00 | $0 | | 09/28/2022 |
| 12/09/2021 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 5.9k | $0.00 | $0 | | 12/09/2021 |
| 11/12/2021 | Acasti Pharma Inc. | ACST | Grant | Stock Options (Right to Buy) | 42.1k | $0.00 | $0 | | 11/12/2021 |
| 12/11/2020 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 10.6k | $0.00 | $0 | | 12/11/2020 |
| 12/18/2019 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 7.8k | $0.00 | $0 | | 12/18/2019 |
| 01/09/2019 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 11.1k | $0.00 | $0 | | 01/09/2019 |
| 06/25/2018 | REV Group, Inc. | REVG | Purchase | Common Stock | 200 | $16.05 | $3.2k | | 06/25/2018 |
| 06/25/2018 | REV Group, Inc. | REVG | Purchase | Common Stock | 400 | $16.06 | $6.4k | | 06/25/2018 |
| 06/25/2018 | REV Group, Inc. | REVG | Purchase | Common Stock | 4.4k | $16.04 | $71.2k | | 06/25/2018 |
| 02/06/2018 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 2.8k | $0.00 | $0 | | 02/06/2018 |
| 01/26/2017 | REV Group, Inc. | REVG | Grant | Restricted Stock Unit | 1.4k | $0.00 | $0 | | 01/26/2017 |
| 02/24/2014 | Merck & Co., Inc. | MRK | Grant | Common Stock | 2.9k | $56.18 | $163.7k | | 02/24/2014 |
| 02/11/2014 | Merck & Co., Inc. | MRK | Sale | Common Stock | 10k | $55.70 | $557k | | 02/11/2014 |
| 02/11/2014 | Merck & Co., Inc. | MRK | Exercise | Stock Option (right to buy) | 10k | $48.24 | $482.4k | | 02/11/2014 |
| 02/25/2013 | Merck & Co., Inc. | MRK | Grant | Common Stock | 2.7k | $42.52 | $113k | | 02/25/2013 |
| 04/24/2012 | Merck & Co., Inc. | MRK | Exercise | Common Stock | 5.8k | $0.00 | $0 | | 04/24/2012 |
| 04/24/2012 | Merck & Co., Inc. | MRK | Payment of Exercise | Common Stock | 2.1k | $38.27 | $80.4k | | 04/24/2012 |
| 04/24/2012 | Merck & Co., Inc. | MRK | Exercise | Restricted Stock Unit | 5.8k | $38.27 | $221k | | 04/24/2012 |
|